However, a large European study found no overall increase in breast cancer for type two diabetic patients, irrespective of type of treatment: sulfonylurea (hazard ratio (HR): 0.98), metformin (HR: 0.90), or insulin (HR: 1.07) [7]. Here, INS is linked to breast carcinoma.